The association between insulin resistance and vascularization of thyroid nodules

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages 184-192

  Wang, Kun ^a   Yang, Yu ^a   Wu, Yang ^b   Chen, Jie ^a   Zhang, Danyu ^a   Mao, Xiaodong ^a   Wu, Xinping ^a   Long, Xianqin ^a   Liu, Chao ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BLOOD VESSEL PARAMETERS; BODY MASS; CHINA; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RESISTIVE INDEX; RISK FACTOR; THYROID NODULE; TUMOR VASCULARIZATION; VASCULAR INDEX; DISEASE COURSE; ECHOGRAPHY; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; THYROID NODULE;

EID: 84920618599     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2723     Document Type: Article

References (34)

1. Samson M, Peale FV Jr., Frantz G, et al. Human endocrine glandderived vascular e ndothelial growth factor: expression early in development and in Leydig cell tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab. 2004;89: 4078-4088.
2. Turner HE, Na gy Z, Gatter KC, Esiri MM, Harris AL, Wass JA. Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab. 2000;85:1159-1162.
3. Antonelli A, Bocci G, Fallahi P, et al. CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo. J Clin Endocrinol Metab. 2014;99:E572-E581.
4. Bakhshaee M, Davoudi Y, Mehrabi M, et al. Vascular pattern and spectral parameters of power Doppler ultrasound as predictors of malignancy risk in thyroid nodules. Laryngoscope. 2008;118:2182-2186.
5. Cantisani V, D'Andrea V, Biancari F, et al. Prospective evaluation of multiparametric ultrasound and quantitative elastosonography in the differential diagnosis of benign and malignant thyroid nodules: preliminary expe rience. Eur J Radiol. 2012;81:2678-2683.
6. Tamsel S, Demirpolat G, Erdogan M, et al. Power Doppler US patterns of vascularity and spectral Doppler US parameters in predicting malignancy in thyr oid nodules. Clin Radiol. 2007;62:245-251.
7. Honors MA, Kinzig KP. Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the yoshida sarcoma. Nutr Cancer. 2014;66:872-878.
8. Anil C, Akkurt A, Ayturk S, Kut A, Gursoy A. Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine def icient area. Metabolism. 2013;62:970-975.
9. Sahin M, Uç an B, Gini Z, et al. Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol. 2013;30: 589.
10. Klubo-Gwiezdzinska J, Costello J Jr., Patel A, et al. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. J Clin Endocrinol Metab. 2013;98:3269-3279.
11. Zhou Q, Liu LZ, Fu B, et al. Reactive oxygen species regulate insulin-induced VEGF and HIF-1-expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis. 2007; 28:28-37.
12. Rose DP, Vona-Davis L. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocr Relat Cancer. 2012;19:R225-R241.
13. Ning G, Reaction Study Group. Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudial (REACTION) study. J Diabetes. 2012;4:172-173.
14. Bi Y,Lu J,Wang W,et al. Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study J Diabetes. 2014 6 147-157.
15. Qiu C, Chen H, Wen J, et al. Associations between age at menarche and menopause with cardiovascular disease, diabetes, and osteoporosis in Chinese women. J Clin Endocrinol Metab. 2013;98:1612-1621.
16. Appetecchia M, Solivetti FM. The association of colour flow Doppler sonography and conventional ultrasonography improves the diagnosis of thyroid carcinoma. Horm Res. 2006;66:249-256.
17. Lyshchik A, Moses R, Barnes SL, et al. Quantitative analysis of tumor vascularity in benign and malignant solid thyroid nodules. J Ultrasound Med. 2007;26:837-846.
18. Bauerle K, Schweppe R, Lund G, et al. Nuclear factor-B-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8. J Clin Endocrinol Metab. 2014;99(8):E1436-E1444.
19. Hoffmann S, Hofbauer LC, Scharrenbach V, et al. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer c ells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors. J Clin Endocrinol Metab. 2004;89:6139-6145.
20. Quek K, Rahul R, Chiew H, Vijay K. Pregnancy-induced accelerated growth and vascularity in a thyroid nodule. J Diagn Med Sonogr. 2008;24:179-182.
21. Wang K, Yang Y, Wu Y, Chen J, Zhang D, Liu C. The association of menstrual and repr oductive factors with thyroid nodules in Chinese women older than 40 years of age [published online July 11, 2014]. Endocrine. doi:10.1007/s12020-014-0342-7.
22. Wong HP, Yu L, Lam EK, Tai EK, Wu WK, Cho CH. Nicotine promotes colon tumor growth and angiogenesis through-Adrenergic activation. Toxicol Sci. 2007;97:279-287.
23. Chammas MC, Gerhard R, de Oliveira IR, et al. Thyroid nodules: evaluation with power Doppler and duplex Doppler ultrasound. Otolaryngol Head Neck Surg. 2005;132:874-882.
24. Tang Y, Zhang D, Fallavollita L, Brodt P. Vascular endothelial growth factorCexpression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor. Cancer Res. 2003; 63:1166-1171.
25. Bunone G, Vigneri P, Mariani L, et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol. 1999;155:1967-1976.
26. Fenton C, Patel A, Dinauer C, Robie DK, Tuttle RM, Francis GL. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor corr elate with the size of papillary thyroid carcinoma in children and young adults. Thyroid. 2000;10:349-357.
27. HuangSM,Lee JC,WuTJ,ChowNH.Clinical relevance of vascular endothelial growth factor for thyroid neoplasms. World J Surg. 2001;25:302-306.
28. Hale LJ, Hurcombe J, Santamaría B, et al. Insulin directly stimulates VEGF-Aproduction in the glomerular podocyte.AmJ Physiol Renal Physiol. 2013;305:F182-F188.
29. Zhan WW, Zhou P, Zhou JQ, Xu SY, Chen KM. Differences in sonographic features of papillary thyroid carcinoma between neck lymph node metastatic and nonmetastatic groups. J Ultras ound Med. 2012;31:915-920.
30. Philippova M, Joshi MB, Pfaff D, et al. T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells. Cardio vasc Res. 2012;93:498-507.
31. De Nicola H, Szejnfeld J, Logullo AF, Wolosker AM, Souza LR, Chiferi V Jr. Flow pattern and vascular resistive index as predictors of malignancy risk in thyroid follicular neoplasms. J Ultrasound Med. 2005;24:897-904.
32. Shaik S, Nucera C, Inuzuka H, Gao D, et al. SCF(-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ub iquitination and destruction of VEGF receptor 2. J Exp Med. 2012;209:1289-1307.
33. Marcello MA, Cunha LL, Batista FA, Ward LS. Obesity and thyroid cancer. Endocr Relat Cancer. 2014;21(5):T255-T271.
34. Sousa PA, Vaisman M, Carneiro JR, et al. Prevalence of goiter and thyroid nodular disease in patients with class III obesity. Arq Bras Endocrinol Metab. 2013;57:120-125.